Effect of calcium carbonate on bioavailability of orally administered gemifloxacin

Antimicrob Agents Chemother. 2003 Jul;47(7):2158-60. doi: 10.1128/AAC.47.7.2158-2160.2003.

Abstract

We investigated the effect of calcium carbonate on the oral bioavailability of gemifloxacin. Gemifloxacin was administered alone, 2 h before, simultaneously, or 2 h after calcium carbonate in 16 volunteers. Data for 320 mg of gemifloxacin alone were as follows: maximum concentration of drug in serum (C(max)),13 microg/ml; half-life, 7.33 h; and area under the concentration-time curve from 0 h to infinity (AUC( infinity )), 6.79 microg. h/ml. Only simultaneous coadministration of calcium carbonate reduced C(max) (-17%) and AUC( infinity ) (-21%) significantly.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Antacids / administration & dosage*
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / adverse effects
  • Anti-Infective Agents / pharmacokinetics*
  • Calcium Carbonate / administration & dosage*
  • Cross-Over Studies
  • Drug Interactions
  • Female
  • Fluoroquinolones*
  • Gemifloxacin
  • Humans
  • Male
  • Naphthyridines / administration & dosage
  • Naphthyridines / adverse effects
  • Naphthyridines / pharmacokinetics*

Substances

  • Antacids
  • Anti-Infective Agents
  • Fluoroquinolones
  • Naphthyridines
  • Calcium Carbonate
  • Gemifloxacin